AI assistant
Grounded Lithium Corp. — Board/Management Information 2020
Feb 6, 2020
43625_rns_2020-02-06_3d2adda0-da5c-4ade-b551-5784d449bc38.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [194 x 53] intentionally omitted <==
News Release No: 20-01
Trading symbol: TSX-V - NEX: CIP.H
Canadian International Pharma Corp. Announces Director and Officer Resignation
West Vancouver, British Columbia – February 6, 2020 – Canadian International Pharma Corp. (the “Company” or “CIPC”) announces that Sead Hamzagic has resigned as a director and as the Chief Financial Officer of the Company.
The Company would like to thank Sead Hamzagic for his considerable efforts and dedication and to wish him well in his future endeavours. Mr. Hamzagic has indicated that he may be available to provide certain accounting services to the Company in the future on a paid consulting basis.
For further information, contact Douglas L. Mason at 604-922-2030.
CANADIAN INTERNATIONAL PHARMA CORP.
“Douglas L. Mason”
____________________________________________ Douglas L. Mason, C.E.O.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this release.
2489 Bellevue Avenue, West Vancouver, BC Canada V7V 1E1 . Tel 604.922.2030 . Fax 604.922.2037